Ftse Mib
33.263,84
1,08%
DAX
18.103,96
0,17%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,00%
Bitcoin
65.395,16
-1,64%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Galera Therapeutics Inc (GRTX) Galera Therapeutics Inc (GRTX) Notizie

GRTX

Galera Therapeutics (GRTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GRTX
DataOraFonteTitoloSimboloCompagnia
07/06/202413:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
16/05/202416:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GRTXGalera Therapeutics Inc
16/05/202416:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GRTXGalera Therapeutics Inc
16/05/202416:25Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GRTXGalera Therapeutics Inc
13/05/202413:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRTXGalera Therapeutics Inc
13/05/202413:00GlobeNewswire Inc.Galera Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
03/05/202413:00GlobeNewswire Inc.Galera Adopts Limited Duration Stockholder Rights AgreementNASDAQ:GRTXGalera Therapeutics Inc
28/03/202412:00GlobeNewswire Inc.Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
26/02/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRTXGalera Therapeutics Inc
21/02/202400:57Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GRTXGalera Therapeutics Inc
14/11/202313:00GlobeNewswire Inc.Galera Reports Third Quarter 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
31/10/202313:09Dow Jones NewsGalera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 TrialNASDAQ:GRTXGalera Therapeutics Inc
31/10/202312:00GlobeNewswire Inc.Galera Announces Receipt of Type A Meeting Minutes and Strategic UpdateNASDAQ:GRTXGalera Therapeutics Inc
18/09/202313:00GlobeNewswire Inc.Galera Schedules Type A Meeting with FDA to Discuss Next Steps for AvasopasemNASDAQ:GRTXGalera Therapeutics Inc
05/09/202313:00GlobeNewswire Inc.Galera to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:GRTXGalera Therapeutics Inc
14/08/202313:00GlobeNewswire Inc.Galera Reports Second Quarter 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
10/08/202302:10Dow Jones NewsStocks to Watch: Applovin, Disney, Galera TherapeuticsNASDAQ:GRTXGalera Therapeutics Inc
09/08/202323:23Dow Jones NewsGalera Therapeutics to Reduce Workforce by 70% to Extend Cash RunwayNASDAQ:GRTXGalera Therapeutics Inc
09/08/202322:31GlobeNewswire Inc.Galera Receives Complete Response Letter from U.S. FDA for Avasopasem ManganeseNASDAQ:GRTXGalera Therapeutics Inc
28/06/202322:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GRTXGalera Therapeutics Inc
16/06/202322:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRTXGalera Therapeutics Inc
05/06/202320:15GlobeNewswire Inc.Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual MeetingNASDAQ:GRTXGalera Therapeutics Inc
18/05/202314:44Dow Jones NewsGalera Therapeutics Gets Orphan Drug Designation for RucosopasemNASDAQ:GRTXGalera Therapeutics Inc
18/05/202314:00GlobeNewswire Inc.Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic CancerNASDAQ:GRTXGalera Therapeutics Inc
11/05/202322:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GRTXGalera Therapeutics Inc
11/05/202313:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GRTXGalera Therapeutics Inc
11/05/202313:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRTXGalera Therapeutics Inc
11/05/202313:00GlobeNewswire Inc.Galera Reports First Quarter 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
04/05/202322:01GlobeNewswire Inc.Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GRTXGalera Therapeutics Inc
01/05/202313:00GlobeNewswire Inc.Galera Expands Commercial Leadership TeamNASDAQ:GRTXGalera Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GRTX

La tua Cronologia

NYSE
NDZ
COIN
WIZUSD
TSXV
GRA
NanoXplore
BIT
UB9GZN
Unicredit Bank
ASX
CCM
Cadoux
LSE
BGD
TSXV
MONY.P
Harmony Acquisitions
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network